Welcome to the USAID-funded Health Policy Plus (HP+) project website.

Links to documents and external sites open in a new window.

Health Policy Plus logoHealth Policy + logo
Skip to contentSkip to footer
HP+ ended September 27, 2022

Better Policy for Better Health

  • About
    • Project Overview
    • Partners
    • Leadership
    • Contact
    • Work with Us
    • Home
  • Our Work
    • Family Planning
    • HIV
    • COVID-19 Response
    • Health Financing
    • Maternal Health
    • Modeling
    • Capacity Development
    • Gender
    • Health Equity
  • Countries
    • Africa
    • Asia
    • Latin America & the Caribbean
  • Resources
    • Publications
    • Models
    • News
    • Viewpoints
    • Conferences & Events
    • Webinars

News

Stakeholders in Nigeria Advance Discussions on Local Production of Antiretroviral Drugs and Test Kit

HP+ Nigeria pictured with stakeholders from the Federal Ministry of Health; Lagos State Agency for AIDS Control Agency; loca pharmaceutical companies; Pharmaceutical Society of Nigeria; Pharmaceutical Manufacturers Group, Manufacturers Association of Nigeria; and implementing partner organizations at the roundtable dialogue meeting. Photo credit: Sabina Ahywa/HP+. 

As part of measures to reduce donor dependence and improve sustainable financing of the HIV program in Nigeria, Health Policy Plus (HP+) hosted a Stakeholder Roundtable Dialogue on Local Production of Antiretroviral Drugs in Lagos, Nigeria on July 13, 2022, to obtain insights and actions that will inform a roadmap. The roadmap will serve as a strategic plan outlining the roles of key actors in ensuring an enabling environment for the local production of ARV drugs in Nigeria. . Successful implementation of the roadmap will advance local production of HIV commodities, thereby increasing access to quality antiretroviral (ARV) drugs and test kits and generally improving HIV outcomes in Nigeria.   

In attendance at the meeting were forty participants from HP+, USAID, the Federal Ministry of Health, Lagos State AIDS Control Agency, Lagos State Health Management Agency, Nigerian Institute for Medical Research, pharmaceutical companies, pharmaceutical associations, UNAIDS, implementing partner organizations, the Lagos state chamber of commerce, civil society organizations, and retail pharmacists.

HP+ presented the findings and recommendations from a technical memo developed on the feasibility, requirements, risks, benefits, potential market size, and availability of local production of HIV commodities (i.e., ARV drugs and test kits) in Nigeria. Some of the challenges identified included difficulty obtaining World Health Organization prequalification for products, insufficient government commitment, lack of guaranteed market purchase, high cost of production inputs, lack of fiscal incentives, increased tariffs, and multiple taxations. In convergence with the technical memo’s recommendations, participants noted that advance market commitment from the government and donors, and enabling a supportive regulatory and policy environment, are necessary preconditions for making progress in the local production of HIV commodities.

While challenges to local manufacturing persist, a representative of the Pharmaceutical Manufacturers Group of the Manufacturers Association of Nigeria remarked, "If the government and donors can guarantee purchase of the ARV drugs we produce, then we can surmount the other hurdles.”

Participants highlighted the need for a sustained multisectoral and multidisciplinary approach while utilizing existing mechanisms and opportunities in a plenary discussion to secure perspectives and recommendations on the roadmap for local production of HIV commodities. Harmonizing policy conversations backed with strong political will is also a key to fast-tracking implementation of local manufacture of HIV commodities in Nigeria.

< Newer Story
Older Story >

Related Materials

Messages of Hope: Reaching Boys and Men with  HIV and AIDS Information
Messages of Hope: Reaching Boys and Men with HIV and AIDS Information
HIV Funding and Financing in Nepal
HIV Funding and Financing in Nepal
Niger Government Signs Decree in Support of Regional Family Planning Services
Niger Government Signs Decree in Support of Regional Family Planning Services
  • About
    • Project Overview
    • Partners
    • Leadership
    • Contact
    • Work with Us
    • Home
  • Our Work
    • Family Planning
    • HIV
    • COVID-19 Response
    • Health Financing
    • Maternal Health
    • Modeling
    • Capacity Development
    • Gender
    • Health Equity
  • Countries
    • Africa
    • Asia
    • Latin America & the Caribbean
  • Resources
    • Publications
    • Models
    • News
    • Viewpoints
    • Conferences & Events
    • Webinars
Privacy Policy Sitemap Staff Intranet

CONTACT US

Health Policy Plus
1331 Pennsylvania Ave NW, Suite 600
Washington, DC 20004
policyinfo@thepalladiumgroup.com

Health Policy Plus (HP+) is a seven-year cooperative agreement funded by the U.S. Agency for International Development under Agreement No. AID-OAA-A-15-00051, beginning August 28, 2015. HP+ is implemented by Palladium, in collaboration with Avenir Health, Futures Group Global Outreach, Plan International USA, Population Reference Bureau, RTI International, ThinkWell, and the White Ribbon Alliance for Safe Motherhood.

USAID-from the American People

The information provided on this website is not official U.S. Government information and does not necessarily represent the views or positions of the U.S. Agency for International Development.

Hosting and © 2016 by For technical issues contact us.webmaster@thepalladiumgroup.com.